These findings suggested that DHMMF may inhibit lipid synthesis in human HCC cells by modulating the functions of SREBP1 and its downstream proteins ACC, FASN and SCD1, thus exerting anti‐HCC effects. The gene discussed is FASN; the disease is hepatocellular carcinoma.